Transcend Therapeutics
Developing the next generation of psychoactive compounds for neuropsychiatry focused on patient access. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€145—218m (Dealroom.co estimates Feb 2023.)
New York City New York (HQ)
Authorizing premium user...